Trials / Sponsors / Zhejiang Doer Biologics Co., Ltd.
Zhejiang Doer Biologics Co., Ltd.
Industry · 6 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects MASLD | Phase 2 | 2025-04-22 |
| Recruiting | Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients Gastrointestinal Cancer | Phase 1 / Phase 2 | 2025-03-25 |
| Completed | A Phase II Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemi Severe Hypertriglyceridemia | Phase 2 | 2024-08-01 |
| Recruiting | Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid T Solid Tumor | Phase 1 | 2023-11-27 |
| Completed | A First in Human (FIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of D Healthy, Obesity, Metabolically | Phase 1 | 2022-06-22 |
| Terminated | A Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DR30303 in Patients Malignant Neoplasm of Digestive System | Phase 1 | 2022-05-13 |